BPC-157: Benefits, Dosage & Side Effects
BPC-157 The ultimate healing peptide What is BPC-157? BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It was first isolated in the early 1990s by researchers studying the stomach
BPC-157
The ultimate healing peptide
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It was first isolated in the early 1990s by researchers studying the stomach's ability to repair itself, and since then it has become one of the most widely researched healing peptides in the bioregulatory space.
Unlike many synthetic compounds, BPC-157 is a partial sequence of a protein your body already produces, which may explain its remarkably low toxicity profile across dozens of animal studies.
The peptide's main claim to fame is accelerated tissue repair. Tendons, ligaments, muscles, the gut lining, and even nerve tissue all respond to BPC-157 in animal models. It works by upregulating growth factor expression (VEGF, EGF, and others), promoting angiogenesis (new blood vessel formation), and modulating nitric oxide pathways. For people dealing with nagging injuries that refuse to heal, or chronic gut issues like leaky gut and IBS symptoms, BPC-157 has become a go-to option in peptide therapy protocols.
One reason BPC-157 stands out from other healing peptides like TB-500 is its versatility. It can be administered via subcutaneous injection near the injury site for localized healing, or taken orally for systemic and gut-specific benefits.
Many users combine it with TB-500 for a synergistic healing stack, since BPC-157 tends to work locally while TB-500 acts systemically. If you are new to peptides and want to calculate the right dose, the BPC-157 Dosage Calculator is a good starting point.
While human clinical trial data remains limited (most studies are in rodents), the sheer volume of positive preclinical evidence is hard to ignore. Over 100 published studies document its protective effects on tissues ranging from the GI tract to the brain. Researchers continue to explore BPC-157's potential for conditions like traumatic brain injury, NSAID-induced gut damage, and peripheral nerve repair.
How BPC-157 Works
BPC-157 operates through several interconnected pathways. Its primary mechanism involves upregulation of growth factor receptors, particularly vascular endothelial growth factor receptor 2 (VEGFR2). This drives angiogenesis, the formation of new blood vessels at the site of injury, which is essential for delivering nutrients and immune cells to damaged tissue.
The peptide also modulates the nitric oxide (NO) system. It appears to restore normal NO levels rather than simply increasing or decreasing them, which helps explain its protective effects in both high-NO conditions (like inflammation) and low-NO conditions (like impaired blood flow). This balancing act sets it apart from simpler anti-inflammatory compounds.
BPC-157 promotes fibroblast migration and collagen deposition, both critical steps in tendon and ligament repair. It also activates the FAK-paxillin pathway, which is involved in cell adhesion, spreading, and migration during wound healing.
In the gut specifically, BPC-157 counteracts damage caused by NSAIDs, alcohol, and stress-induced lesions by stabilizing the mucosal barrier and promoting epithelial cell turnover. For a detailed look at the alcohol research, see our BPC-157 and alcohol guide. There is also evidence it interacts with the dopaminergic system, which may explain reported improvements in mood and the peptide's neuroprotective properties in models of brain injury.
Benefits of BPC-157
Tendon and Ligament Repair BPC-157 has shown consistent results in accelerating the healing of tendons and ligaments across multiple animal studies. In rat models with severed Achilles tendons, BPC-157 treatment led to faster functional recovery and improved collagen fiber organization compared to controls. This is the benefit that attracts most users: stubborn tendinopathies, partial tears, and repetitive strain injuries that plateau with rest alone.
Gut Health and Mucosal Protection As a peptide derived from gastric juice, BPC-157 has a natural affinity for the GI tract. Studies show it protects against NSAID-induced stomach ulcers, heals inflammatory bowel lesions, and restores gut barrier integrity. Users with leaky gut, IBS, or chronic NSAID use often report noticeable improvements. Oral administration is especially effective for gut-specific benefits.
Muscle Recovery BPC-157 accelerates muscle healing after crush injuries in animal studies. It promotes angiogenesis within damaged muscle tissue and reduces fibrosis (scar tissue formation), leading to better functional recovery. Athletes and lifters use it to speed up recovery from strains and overtraining.
Neuroprotection Several studies demonstrate BPC-157's ability to protect the brain and peripheral nerves. In rat models of traumatic brain injury, it reduced brain edema and improved neurological outcomes. It has also shown promise in models of peripheral nerve transection, promoting faster nerve regeneration.
Anti-Inflammatory Effects BPC-157 does not simply suppress inflammation like a corticosteroid. Instead, it appears to modulate inflammatory cascades, reducing excessive inflammation while preserving the constructive inflammatory response needed for healing. This makes it a better fit for injury recovery than blunt anti-inflammatory drugs.
These benefits pair well with Ipamorelin for users who want to boost growth hormone levels alongside tissue repair, or with TB-500 for a full-spectrum healing protocol.
Side Effects & Safety
Common Side Effects - Mild discomfort or redness at the injection site - Slight nausea when taken orally on an empty stomach (usually temporary) - Occasional dizziness in the first few days of use
Less Common Side Effects - Lightheadedness or fatigue (typically resolves within a week) - Mild headache - Slight changes in appetite
Contraindications and Cautions - BPC-157 has not been tested in human clinical trials for safety. All safety data comes from animal studies, where it has shown a very favorable profile with no recorded LD50 (lethal dose). - Individuals with active cancer should avoid BPC-157 due to its pro-angiogenic effects. New blood vessel formation could theoretically support tumor growth. - Pregnant or breastfeeding women should not use this peptide. - If you are taking blood-thinning medications, consult a doctor before use, as BPC-157 may interact with coagulation pathways. - People with a history of blood clots should use caution.
For a detailed breakdown, see our BPC-157 side effects guide. For gut-specific protocols including BPC-157 stacking, see Peptides for Gut Health.
BPC-157 Dosage Protocols
Beginner Protocol
250 mcg/day
Once daily
4 weeks
Standard Protocol
500 mcg/day
Once daily (or split 250 mcg twice daily)
4-8 weeks
Advanced Protocol
500-750 mcg/day
Twice daily (split dose)
6-8 weeks
Beginner Protocol: Inject subcutaneously near the injury site, or take orally for gut-specific benefits. Good starting point to assess tolerance.
Standard Protocol: The most commonly used dose in community protocols. Splitting the dose morning and evening may provide more consistent levels given the ~4 hour half-life.
Advanced Protocol: For severe or chronic injuries. Often stacked with TB-500. Follow with at least 2 weeks off before repeating.
These are general guidelines for research purposes. Always consult a healthcare professional before use.
Is BPC-157 Right for You?
Take our quiz to get a personalized recommendation based on your goals and profile.
Stacking BPC-157
Synergistic healing: BPC-157 works locally while TB-500 works systemically
BPC-157 at 250-500 mcg/day (injected near injury) + TB-500 at 2-2.5 mg twice per week. Run for 4-8 weeks. This is the most popular healing stack in the peptide community.
Enhanced recovery by adding growth hormone release to tissue repair
BPC-157 at 250-500 mcg/day + Ipamorelin at 200-300 mcg before bed. The elevated GH from Ipamorelin supports connective tissue synthesis and complements BPC-157's direct healing effects.
Sustained GH elevation for long-term recovery support
BPC-157 at 500 mcg/day + CJC-1295 (DAC) at 2 mg per week. Best for users who want ongoing tissue repair support with improved sleep and body composition benefits.
Frequently Asked Questions
Both routes work, but they serve different purposes. Oral BPC-157 is particularly effective for gut-related issues (leaky gut, IBS, NSAID damage) since it acts directly on the GI lining. For localized injury healing (tendons, muscles, joints), subcutaneous injection near the injury site delivers the peptide more directly to the tissue. Some users do both: oral for systemic/gut benefits and injection for a specific injury.
Most users report noticeable improvements within 1-2 weeks for acute injuries, though chronic conditions may take 4-6 weeks. Gut issues often respond within the first week. The timeline varies based on injury severity, dosage, and whether you are stacking with other peptides.
Animal studies have not identified significant toxicity even at very high doses, and no LD50 has been established. That said, most protocols recommend cycling (4-8 weeks on, 2-4 weeks off) rather than continuous use. Long-term human safety data does not exist yet, so a cautious cycling approach makes sense.
BPC-157 is not currently tested for in standard workplace drug panels. However, WADA (World Anti-Doping Agency) has banned it for competitive athletes since 2022. If you compete in sanctioned sports, do not use BPC-157.
BPC-157 works best locally, targeting the specific area where it is injected or (in the case of oral dosing) the gut. TB-500 acts systemically throughout the body, promoting healing in multiple areas at once. BPC-157 primarily drives angiogenesis and growth factor expression, while TB-500 promotes cell migration and differentiation. Most healing protocols stack both for the best results. See the TB-500 page for more details.
For injury healing, inject subcutaneously as close to the injury site as possible. For example, if you have a knee tendon issue, inject in the fatty tissue around the knee. For general systemic use, the abdominal fat pad works well. Always rotate injection sites slightly to avoid tissue irritation.
This is one of BPC-157's most well-studied applications. Multiple animal studies show it reverses NSAID-induced gastric damage, restores the mucosal lining, and counteracts intestinal inflammation caused by drugs like ibuprofen and aspirin. Oral administration is preferred for this purpose. Many users report significant improvement in symptoms within 1-3 weeks.
Not Sure Which Peptide Protocol Is Right for You?
Take our 2-minute quiz for a personalized recommendation based on your goals and health profile.